We are passionate about making a positive impact on the lives of mesothelioma patients and their families, not just in the courtroom. To that end, we are proud to work with the following top-quality advocacy groups and non-profit organizations.
We are extremely proud to sponsor initiatives to help the mesothelioma community, whether that means aiding the fight against asbestos worldwide or working to help fight the medical battle against this terrible disease. The following are some of the groups that we have supported:
The Asbestos Disease Awareness Organization (ADAO) is an independent non-profit organization founded to fight mesothelioma by bringing attention to the need for innovative medial treatments and advocating for a global ban on asbestos.
ADAO, founded by Doug Larkin and Linda Reinstein (who lost her husband to the disease), is a key organization in the fight against asbestos worldwide. We are proud to have sponsored the groundbreaking work performed by ADAO. Baron and Budd was a 2012-2013 platinum sponsor of ADAO and a 2011 gold sponsor.
The president and managing shareholder of Baron & Budd, Russell Budd, was formerly a member of the philanthropic arm of the NCCN, the NCCN Foundation Board.
Our law firm sponsored the creation of the NCCN Patient Guides for Mesothelioma because we saw the need for materials about mesothelioma written specifically for patients and their families. These patient guidelines, translated from the NCCN Clinical Guidelines, provided a detailed guide to help patients and caregivers better understand this form of cancer. The guide includes information about how to effectively communicate with medical professionals and navigate different treatment options for mesothelioma.
Baron & Budd was proud to provide a substantial donation that helped Dr. David Sugarbaker establish the International Mesothelioma Program (IMP) at Brigham and Women’s Hospital in Boston. Many people suffering from pleural mesothelioma have benefited from the cutting-edge treatments offered by the program. The mission of the program is to research new screening tools that can help doctors detect mesothelioma earlier, as well as to develop effective treatments and medications for the disease.
The CURE Media Group publishes CURE magazine and is dedicated to providing patients, caregivers and families with easy-to-understand information regarding mesothelioma. It can be difficult for patients and caregivers to be able to find accessible material regarding mesothelioma because the disease is so rare. To help correct this problem, we partnered with CURE to publish the book Understanding Mesothelioma, which was most recently updated in 2013.
CURE media group, the publishers of CURE magazine, is dedicated to providing patient-friendly information about cancer to families, patients and caregivers throughout their cancer journey. Because mesothelioma is so rare, it can be difficult for patients to find accessible material, so we partnered with CURE to publish the book Understanding Mesothelioma.